Readable research linked to original sources
Articles
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
6 articles
Newest firstIntroduction Washington state's adult use cannabis market operates under regulations by the Washington State Liquor and Cannabis Board to restrict access and promotion among young people. Cannabis edibles sold in the state are required to contain specific labels that inform consumers that the product contains cannabis and provide contact information for Poison Control. However, it is unclear how teens perceive suc…
Open article record in new tab ↗Background In Colorado, regulations for recreational and medical cannabis sales require tetrahydrocannabinol (THC) concentration is printed on all products. Labeled THC concentrations can vary by +/-15% of what is in the product. Studies show THC concentrations recorded on product labels are not always reflective of the THC concentration in the cannabis product and there is evidence consumers make purchasing decis…
Open article record in new tab ↗Importance Cannabis edibles have increased in popularity, particularly among young adults and in states with recreational cannabis legalization. Little is known about the association of cannabis packaging regulations with health warning recall and perceptions. Objective To evaluate whether features of packaging are associated with ability to recall health warnings as well as perceptions of cannabis edible products…
Open article record in new tab ↗This case series compares amounts of tetrahydrocannabinol and cannabidiol reported on product labels vs levels found in laboratory testing in legal oral cannabis oil products in Ontario, Canada.
Open article record in new tab ↗Introduction: The unmet need for highly effective, naturally derived products with minimal side effects results in the over-popularity of ever-newer medicinal plants. In the middle of 2010, products containing cannabidiol (CBD), one of the special metabolites of Cannabis sativa, started to gain popularity. For consumers and healthcare providers alike, the legal context surrounding the marketing of CBD products is…
Background Cannabidiol (CBD), a safe, non-intoxicating cannabis component, is growing in popularity in Europe and worldwide. However, CBD EU regulation is blurry, and consequent labelling and product quality issues may have implications for public health. There is therefore a need to assess the prevalence and perceived harmfulness of CBD use in EU countries, as well as to characterise CBD users. We aimed to do so…
Open article record in new tab ↗